Rise In The Demand For Prothrombin Time Tests In Hospitals is Driving The Growth of The Hemostasis-Coagulation Analysis Market

The Rise in the Demand for Advanced Clinical Laboratory Analyzers and Point-of-Care Testing Analyzers to Enhance the Quality of Life of Patients Suffering from Thrombotic and Bleeding Disorders is Anticipated to Boost the Hemostasis-Coagulation Analysis Market During the Forecast Period 2021-2026. Hemostasis-coagulation Analysis Market Size Is Estimated To Reach $5.3 Billion By 2026, Growing At A CAGR of 9.6% During The Forecast Period 2021-2026. 

The Hemostasis-Coagulation Analysis Market is growing at a significant rate owing to its iincreasing demand for advanced clinical laboratory analyzers and point-of-care testing analyzers to enhance the quality of life of patients suffering from thrombotic and bleeding disorders. Hemostasis-coagulation analyzers prevent blood clots that cause heart attacks and follow simple steps to measure platelet levels. Additionally, advancements in optical and electrochemical technologies and growing investment by the key players to develop high-quality technologies are also estimated to propel the market during the forecast period 2021-2026.

Hemostasis-coagulation analyzers run by the principle of optical detection method by detecting change caused in the intensity of scattered light and turbidity during the blood coagulation. These coagulation analyzers have the ability to analyze compromised icteric and lipemic samples in three minutes and include rapid optical, chromogenic, and immunoturbidimetric assays for routine and testing. These analyzers also provide flexibility, advanced proprietary mechanical testing methods, and eliminate much of the uncertainty and assay repetition to enhance the quality of life of patients suffering from bleeding disorders. These coagulation analyzers are also used for measuring the pathway speed of thromboplastin levels in a very short time. These analyzers were built-in security lockout protocols for secure use, as they are used to obtain sensitive information about the patient health. Researchers across the world are investing huge amounts to develop and install advanced hemostasis-coagulation analyzers in public healthcare facilities, such as hospitals and clinical laboratories.

North America dominated the market share of the Hemostasis-Coagulation Analysis Market in 2020 owing to the increasing availability of advanced hemostasis-coagulation analyzers in hospitals and clinical laboratories. Governments in developed nations are creating awareness about the presence of high-quality technologies among patients suffering thrombotic thrombocytopenic purpura (TTP) to enhance the diagnostic rate and preventive care management, which is estimated to propel the growth of the Hemostasis-Coagulation Analysis Market.

Hemostasis-coagulation analyzers are increasingly being adopted across the world owing to the growing incidences of hemorrhage and various lifestyle-associated diseases. Governments of various nations are also providing funds to develop hemostasis-coagulation analyzers for the treatment of these diseases, which is one of the major factors driving the growth of the Hemostasis-Coagulation Analysis Market.

The prothrombin time (PT) tests are increasingly being used to evaluate the common pathway and extrinsic pathway of coagulation and to determine the clotting tendency, in the measure of liver damage, warfarin dosage, and vitamin K status. These tests are also used in conjunction with the activated partial thromboplastin time (APTT) to measure the common pathway and intrinsic pathway of coagulation, which is propelling the growth of the Hemostasis-Coagulation Analysis Market.

In July 2020, Sysmex has launched next-generation automated hemostasis coagulation analyzers CN-3000 and CN-6000 to enhance the quality of life of patients suffering from thrombotic and bleeding disorders and to increase the number of tests performed for therapy monitoring and diagnoses.

The Major Players in this Market Include

The major companies in the Hemostasis-Coagulation Analysis Market include Abbott Laboratories, Danaher, Sysmex Group, Thermo Fisher Scientific, Nihon Kohden, Bio Group Medical System, Genrui Biotech Inc, Instrumentation Laboratory, Helena Laboratories, and Siemens Healthineers Group.

Over the years, major market players have focused on various technologies, such as mechanical, optical, and electrochemical that are used for various blood disorders. The launch of new market companies and government-aided policies have propelled the development of hemostasis-coagulation analyzers. The continuous developments in the Hemostasis-Coagulation Analysis Market, such as advanced technologies, increasing funding amount of startups and research organizations, and surge in the number of product launches are the major factors set to drive the Hemostasis-Coagulation Analysis Market during the forecast period 2021-2026.